Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2024-11-01

Clinical Trial Update: Liposomal Iron 30 mg Supplement in Non-anemic Pregnant Females

View source ↗

Summary

A clinical trial is evaluating a liposomal iron 30 mg supplement in non-anemic pregnant women for anemia-related conditions, with recruitment not yet started.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Liposomal Iron 30 mg Supplement (liposomal iron)

Snippet

Sponsor: Orchidia pharmaceutical Industries | Conditions: Anemia of Pregnancy, Iron Deficiency Anemia | Status: NOT_YET_RECRUITING